Abstract 1730: Onvansertib in combination with carboplatin demonstrates enhanced anti-tumorigenic effects in pre-clinical models of serous endometrial cancer
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409631243
